Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioTTT001 with SOX and Toripalimab in Gastric Cancer Peritoneal Metastases
NCT06283121Phase 2Not yet recruiting
- Sponsor
- China Medical University
- Start
- Apr 2024
- Primary completion
- Nov 2027
- Modality
- Oncolytic Viruses
01
Overview
A Phase 2 trial of BioTTT001 in gastric cancer (GC), sponsored by China Medical University. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
BioTTT001
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT06283121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06283121.